The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

They investigated 12 medications — three that the US Food and Drug Administration (FDA) has approved for weight loss and nine it hasn’t. The drugs mimic GLP-1, a hormone the body naturally ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower ...

Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...